08-31-2023
DKK/share | |
Price | 30.72 |
Dividend | 0.58 |
Earnings | 17.07 |
Cash-flow | 18.07 |
Book value | 102.40 |
Equity | 99.24 |
H. Lundbeck is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. H. Lundbeck is a company from Denmark, and his stocks are publicly traded.
H. Lundbeck stock dividend
H. Lundbeck paid a total dividend of 115 million DKK last year, for a market value of 6,113 millions (Market Cap 1,216 millions). H. Lundbeck dividend per share is 0.58 DKK, and his stock market price 30.72 DKK.
According to the chart below, where dividend yield is displayed, H. Lundbeck has a dividend yield of 1.89%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.
In addition, you should compare H. Lundbeck stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Denmark dividend stocks list.
H. Lundbeck Dividend Payout
About the ability of H. Lundbeck to maintain his current dividend of DKK 0.58 per share, an amount that accounts for 1.89%, we should study its payout ratio both on earnings and on cash-flows (see chart below). H. Lundbeck payout on ernings is currently 3.40%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that H. Lundbeckcan maintain his current dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of H. Lundbeck is DKK 18.07 per share, which is higher than the dividend per share paid by the company of DKK 0.58, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of H. Lundbeck, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
H. Lundbeck Dividend History
Below you will find a table with the historical evolution of H. Lundbeck's dividend stock, both in percentage and in DKK, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | DKK | Paypout | Shares* |
Present | 1.89% | 0.58 | 3.40% | 199 |
2022 | 8.38% | 2.00 | 15.07% | 199 |
2021 | 1.48% | 2.50 | 15.55% | 199 |
2020 | 1.96% | 4.09 | 22.72% | 199 |
2019 | 4.72% | 12.01 | 50.04% | 199 |
2018 | 2.80% | 7.99 | 43.69% | 199 |
2017 | 0.78% | 2.46 | 21.01% | 198 |
2016 | 0.00% | 0.00 | 0.00% | 197 |
2015 | 0.00% | 0.00 | 0.00% | 197 |
*In millions
Then you can see the evolution of H. Lundbeck dividend stock, and compare it with the average of Denmark stocks and that of the Pharmaceuticals and Biotechnology stocks.
H. Lundbeck Stock performance
Finally, last moth H. Lundbeck showed a return of 1.10% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 8.40% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.